» Articles » PMID: 20861418

The Cytoprotective Effects of Dantrolene: a Ryanodine Receptor Antagonist

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2010 Sep 24
PMID 20861418
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Calcium, as a second messenger, has an important role in a variety of cellular functions. However, disruption of intracellular calcium homeostasis leads to cytotoxicity and cell death. Excessive calcium release from intracellular stores, via the calcium channel ryanodine receptor, contributes to cell damage. Dysfunction of calcium homeostasis is established in tissue culture and animal models of ischemia, hypoxia, seizure, trauma, anesthesia, and neurodegenerative diseases. Dantrolene, the primary drug to treat malignant hyperthermia, is a ryanodine receptor antagonist. Dantrolene inhibits abnormal calcium release from the sarco-endoplasmic reticulum, which is the primary intracellular calcium store. Dantrolene has been investigated widely for its possible cytoprotective effects against cell damage in different tissue culture or animal models of diseases involving cytotoxicity induced by disruption of intracellular calcium homeostasis in pathogenesis. In this review, we summarize the role of the disruption of intracellular calcium homeostasis on cell death, the pharmacologic and pharmacokinetic features of dantrolene, and the cytoprotective effects and potential application of dantrolene for the inhibition of cell damage in a wide variety of models of stress and disease.

Citing Articles

Anesthesia-induced Developmental Neurotoxicity in Pediatric Population.

Chaudhary F, Agrawal D J Surg Res (Houst). 2024; 7(4):490-500.

PMID: 39687550 PMC: 11649317. DOI: 10.26502/jsr.10020400.


Management of Suspected α-Pyrrolidinoisohexanophenone (α-PiHP)-Related Hyperthermia in a Young Adult: A Case Report.

Tkind T, Vialatte P, Roger C, Saadi L, Muller L Cureus. 2024; 16(10):e70708.

PMID: 39493037 PMC: 11530085. DOI: 10.7759/cureus.70708.


Purinergic agonists increase [Ca] in rat conjunctival goblet cells through ryanodine receptor type 3.

Fjaervoll H, Fjaervoll K, Yang M, Reiten O, Bair J, Lee C Am J Physiol Cell Physiol. 2024; 327(3):C830-C843.

PMID: 39099424 PMC: 11427011. DOI: 10.1152/ajpcell.00291.2024.


Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment.

Hunt M, Wang N, Pupinyo N, Curman P, Torres M, Jebril W EMBO Mol Med. 2024; 16(9):1986-2001.

PMID: 39060641 PMC: 11392931. DOI: 10.1038/s44321-024-00104-3.


Current clinical application of dantrolene sodium.

Yang H, Choi J, In J, Sung T, Kim Y, Sultana S Anesth Pain Med (Seoul). 2023; 18(3):220-232.

PMID: 37691593 PMC: 10410554. DOI: 10.17085/apm.22260.


References
1.
MacManus A, Ramsden M, Murray M, Henderson Z, Pearson H, Campbell V . Enhancement of (45)Ca(2+) influx and voltage-dependent Ca(2+) channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta. J Biol Chem. 2000; 275(7):4713-8. DOI: 10.1074/jbc.275.7.4713. View

2.
Sattler R, Tymianski M . Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med (Berl). 2000; 78(1):3-13. DOI: 10.1007/s001090000077. View

3.
Zhang L, Andou Y, Masuda S, Mitani A, Kataoka K . Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci Lett. 1993; 158(1):105-8. DOI: 10.1016/0304-3940(93)90623-s. View

4.
Furuichi T, Furutama D, Hakamata Y, Nakai J, Takeshima H, Mikoshiba K . Multiple types of ryanodine receptor/Ca2+ release channels are differentially expressed in rabbit brain. J Neurosci. 1994; 14(8):4794-805. PMC: 6577160. View

5.
Aslan A, Cemek M, Buyukokuroglu M, Altunbas K, Bas O, Yurumez Y . Dantrolene can reduce secondary damage after spinal cord injury. Eur Spine J. 2009; 18(10):1442-51. PMC: 2899378. DOI: 10.1007/s00586-009-1033-6. View